• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩展的结合角度的三齿钌(II) 多吡啶配合物对哺乳动物细胞和多细胞肿瘤球体的光毒性。

Phototoxicity of Tridentate Ru(II) Polypyridyl Complex with Expanded Bite Angles toward Mammalian Cells and Multicellular Tumor Spheroids.

机构信息

School of Chemical Sciences and National Centre for Sensor Research, Dublin City University, Dublin 9 D09 NA55, Ireland.

National Institute for Cellular Biotechnology, School of Biotechnology, Dublin City University, Dublin 9 D09 NA55, Ireland.

出版信息

Inorg Chem. 2023 Aug 14;62(32):13089-13102. doi: 10.1021/acs.inorgchem.3c01982. Epub 2023 Aug 3.

DOI:10.1021/acs.inorgchem.3c01982
PMID:37535942
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10428208/
Abstract

Tridentate ligand-coordinated ruthenium (II) polypyridyl complexes with large N-Ru-N bite angles have been shown to promote ligand field splitting and reduce singlet-triplet state mixing leading to dramatically extended emission quantum yields and lifetimes under ambient conditions. These effects are anticipated to enhance their photoinduced singlet oxygen production, promoting prospects for such complexes as type II phototherapeutics. In this contribution, we examined this putative effect for [Ru(bqp)(bqpCOOEt)], Ru-bqp-ester, a heteroleptic complex containing bqp = [2,6-bi(quinolin-8-yl)pyridine], a well-established large bite angle tridentate ligand, as well as its peptide conjugates [Ru(bqp)(bqpCONH-ahx-FrFKFrFK(Ac)-CONH)] (Ru-bqp-MPP) and [Ru(bqp) (bqp)(CONH-ahx-RRRRRRRR-CONH)] (Ru-bqp-R8) that were prepared in an effort to promote live cell/tissue permeability and targeting of the parent. Membrane permeability of both parent and peptide conjugates were compared across 2D cell monolayers; A549, Chinese hamster ovary, human pancreatic cancer (HPAC), and 3D HPAC multicellular tumor spheroids (MCTS) using confocal microscopy. Both the parent complex and peptide conjugates showed exceptional permeability with rapid uptake in both 2D and 3D cell models but with little distinction in permeability or distribution in cells between the parent or peptide conjugates. Unexpectedly, the uptake was temperature independent and so attributed to passive permeation. Both dark and photo-toxicity of the Ru(II) complexes were assessed across cell types, and the parent showed notably low dark toxicity. In contrast, the parent and conjugates were found to be highly phototoxic, with impressive phototoxic indices (PIs) toward HPAC cell monolayers in particular, with PI values ranging from ∼580 to 760. Overall, our data indicate that the Ru(II) parent complex and its peptide conjugates show promise at both cell monolayers and 3D MCTS as photosensitizers for photodynamic therapy.

摘要

具有大 N-Ru-N 夹角的三齿配体配位的钌(II)多吡啶配合物已被证明能促进配体场分裂,减少单重态-三重态混合,从而在环境条件下显著延长发射量子产率和寿命。预计这些效应会增强它们的光诱导单线态氧产生,从而提高这些配合物作为 II 型光疗剂的前景。在本研究中,我们考察了 [Ru(bqp)(bqpCOOEt)],Ru-bqp-ester 的这种假定效果,Ru-bqp-ester 是一种包含 bqp = [2,6-双(喹啉-8-基)吡啶]的杂配体配合物,bqp 是一种成熟的大夹角三齿配体,以及它的肽缀合物 [Ru(bqp)(bqpCONH-ahx-FrFKFrFK(Ac)-CONH)](Ru-bqp-MPP)和 [Ru(bqp)(bqp)(CONH-ahx-RRRRRRRR-CONH)](Ru-bqp-R8),它们被制备以提高母体的细胞/组织通透性和靶向性。通过共聚焦显微镜比较了母体和肽缀合物在 2D 细胞单层;A549、中国仓鼠卵巢、人胰腺癌细胞(HPAC)和 3D HPAC 多细胞肿瘤球体(MCTS)中的膜通透性。母体复合物和肽缀合物都表现出异常的通透性,在 2D 和 3D 细胞模型中都有快速摄取,但在细胞内母体或肽缀合物之间的通透性或分布几乎没有区别。出乎意料的是,摄取与温度无关,因此归因于被动渗透。在细胞类型中评估了 Ru(II)配合物的暗毒性和光毒性,母体表现出明显的低暗毒性。相比之下,母体和缀合物被发现具有高度的光毒性,特别是对 HPAC 细胞单层具有令人印象深刻的光毒性指数(PI),PI 值范围从∼580 到 760。总体而言,我们的数据表明,Ru(II)母体配合物及其肽缀合物在细胞单层和 3D MCTS 中均具有作为光动力治疗光敏剂的应用潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/06b0f220dedf/ic3c01982_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/45c069902caf/ic3c01982_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/b42039676ecd/ic3c01982_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/7fefd6fa9a1a/ic3c01982_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/23dd38da51c7/ic3c01982_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/b592b3a69774/ic3c01982_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/e7d212a9cc39/ic3c01982_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/06b0f220dedf/ic3c01982_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/45c069902caf/ic3c01982_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/b42039676ecd/ic3c01982_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/7fefd6fa9a1a/ic3c01982_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/23dd38da51c7/ic3c01982_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/b592b3a69774/ic3c01982_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/e7d212a9cc39/ic3c01982_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa95/10428208/06b0f220dedf/ic3c01982_0008.jpg

相似文献

1
Phototoxicity of Tridentate Ru(II) Polypyridyl Complex with Expanded Bite Angles toward Mammalian Cells and Multicellular Tumor Spheroids.扩展的结合角度的三齿钌(II) 多吡啶配合物对哺乳动物细胞和多细胞肿瘤球体的光毒性。
Inorg Chem. 2023 Aug 14;62(32):13089-13102. doi: 10.1021/acs.inorgchem.3c01982. Epub 2023 Aug 3.
2
Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.Ru(II) 金属卟啉配合物作为单光子和双光子光动力治疗光敏剂的应用的关键综述。
Acc Chem Res. 2017 Nov 21;50(11):2727-2736. doi: 10.1021/acs.accounts.7b00180. Epub 2017 Oct 23.
3
Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.β-咔啉配体的 Ir(III)和 Ru(II) 多吡啶配合物的抗癌光动力活性研究进展。
Eur J Med Chem. 2024 Oct 5;276:116618. doi: 10.1016/j.ejmech.2024.116618. Epub 2024 Jun 28.
4
Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.设计一种具有红光激发和显著提高的光生物活性的三齿杂配钌(II)配合物。
Inorg Chem. 2020 Aug 3;59(15):11193-11204. doi: 10.1021/acs.inorgchem.0c01860. Epub 2020 Jul 23.
5
Photostable NIR emitting ruthenium(II) conjugates; uptake and biological activity in live cells.光稳定的近红外发光钌(II)共轭物;活细胞中的摄取和生物活性。
J Inorg Biochem. 2020 Jun;207:111032. doi: 10.1016/j.jinorgbio.2020.111032. Epub 2020 Feb 14.
6
Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.带有噻吩基的 π-扩展环金属化配体的钌(II)配合物的光物理性质和光生物活性。
Inorg Chem. 2019 Aug 19;58(16):10778-10790. doi: 10.1021/acs.inorgchem.9b01044. Epub 2019 Aug 6.
7
Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.两种钌(II)多吡啶配合物作为单光子和双光子光动力疗法光敏剂的药用潜力评估
Chemistry. 2017 Jul 21;23(41):9888-9896. doi: 10.1002/chem.201701392. Epub 2017 Jun 29.
8
π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.作为光动力疗法的反向饱和吸收剂和光敏剂的π-扩展异核钌(II)配合物
Inorg Chem. 2017 Mar 20;56(6):3245-3259. doi: 10.1021/acs.inorgchem.6b02624. Epub 2017 Mar 6.
9
Predictive Strength of Photophysical Measurements for in Vitro Photobiological Activity in a Series of Ru(II) Polypyridyl Complexes Derived from π-Extended Ligands.源自π-扩展配体的一系列钌(II)多吡啶配合物的光物理测量对体外光生物活性的预测强度。
Inorg Chem. 2019 Mar 4;58(5):3156-3166. doi: 10.1021/acs.inorgchem.8b03223. Epub 2019 Feb 14.
10
Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy.聚合物包裹钌多吡啶配合物用于肿瘤靶向的单光子和双光子光动力治疗。
ACS Appl Mater Interfaces. 2020 Dec 9;12(49):54433-54444. doi: 10.1021/acsami.0c16119. Epub 2020 Nov 25.

引用本文的文献

1
Biomimetic Tumour Model Systems for Pancreatic Ductal Adenocarcinoma in Relation to Photodynamic Therapy.用于胰腺导管腺癌光动力治疗的仿生肿瘤模型系统
Int J Mol Sci. 2025 Jul 2;26(13):6388. doi: 10.3390/ijms26136388.
2
Enhancing Phototoxicity in BODIPY-Perylene Charge Transfer Dyads by Combined Iodination and Mesylation.通过碘化和甲磺酰化联用增强硼二吡咯-苝电荷转移二元体系的光毒性
Chemistry. 2024 Dec 18;30(71):e202403149. doi: 10.1002/chem.202403149. Epub 2024 Nov 9.
3
Cell viability imaging in tumor spheroids DNA binding of a ruthenium(II) light-switch complex.

本文引用的文献

1
Near-infrared-II-activatable sulfur-deficient plasmonic BiS-Au heterostructures for photoacoustic imaging-guided ultrasound enhanced high performance phototherapy.近红外二区激活的硫缺陷等离子体 BiS-Au 杂化结构用于光声成像引导的超声增强高效光热治疗。
J Colloid Interface Sci. 2023 Aug 15;644:437-453. doi: 10.1016/j.jcis.2023.04.108. Epub 2023 Apr 25.
2
Selective, Disruptive Luminescent Ru(II) Polypyridyl Probes of G-Quadruplex.选择性、破坏型的 G-四链体的 Ru(II) 多吡啶探针。
Inorg Chem. 2023 Feb 6;62(5):2213-2227. doi: 10.1021/acs.inorgchem.2c03903. Epub 2023 Jan 26.
3
Ru(II) CONTAINING PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY: A CRITIQUE ON REPORTING AND AN ATTEMPT TO COMPARE EFFICACY.
肿瘤球体中的细胞活力成像 钌(II)光开关配合物的DNA结合
Chem Commun (Camb). 2024 Jun 13;60(49):6308-6311. doi: 10.1039/d4cc01425a.
用于光动力疗法的含钌(II)光敏剂:关于报告的评论及疗效比较尝试
Coord Chem Rev. 2022 Nov 1;470. doi: 10.1016/j.ccr.2022.214712. Epub 2022 Jul 26.
4
Copper-Nitrogen-Coordinated Carbon Dots: Transformable Phototheranostics from Precise PTT/PDT to Post-Treatment Imaging-Guided PDT for Residual Tumor Cells.铜-氮-配位碳点:从精准光热治疗/光动力治疗到治疗后成像指导光动力治疗残留肿瘤细胞的可转换光热/光动力治疗一体化。
ACS Appl Mater Interfaces. 2023 Jan 18;15(2):3253-3265. doi: 10.1021/acsami.2c17525. Epub 2023 Jan 4.
5
Liposomal Binuclear Ir(III)-Cu(II) Coordination Compounds with Phosphino-Fluoroquinolone Conjugates for Human Prostate Carcinoma Treatment.具有膦基-氟喹诺酮共轭物的脂质体双核 Ir(III)-Cu(II)配合物用于人类前列腺癌治疗。
Inorg Chem. 2022 Dec 5;61(48):19261-19273. doi: 10.1021/acs.inorgchem.2c03015. Epub 2022 Nov 16.
6
Strategic Design of Luminescent Rhenium(I), Ruthenium(II), and Iridium(III) Complexes as Activity-Based Probes for Bioimaging and Biosensing.基于活性的生物成像和生物传感用镧系元素(I)、钌(II)和铱(III)配合物的荧光探针的战略设计。
Chem Asian J. 2022 Nov 16;17(22):e202200840. doi: 10.1002/asia.202200840. Epub 2022 Oct 17.
7
Recent advances in noble metal complex based photodynamic therapy.基于贵金属配合物的光动力疗法的最新进展
Chem Sci. 2022 Apr 1;13(18):5085-5106. doi: 10.1039/d1sc05478c. eCollection 2022 May 11.
8
Recent advances in spheroid-based microfluidic models to mimic the tumour microenvironment.基于球体的微流控模型在模拟肿瘤微环境方面的最新进展。
Analyst. 2022 May 17;147(10):2023-2034. doi: 10.1039/d2an00172a.
9
Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.影响光激活钌类抗癌化合物生成单线态氧与配体取代的因素。
Curr Opin Chem Biol. 2022 Jun;68:102143. doi: 10.1016/j.cbpa.2022.102143. Epub 2022 Apr 25.
10
Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (IL) Excited States.用于近红外光动力疗法的钌光敏剂需要最低能量的三重态配体内(IL)激发态。
J Photochem Photobiol. 2021 Dec;8. doi: 10.1016/j.jpap.2021.100067. Epub 2021 Sep 15.